MedPath

Alveolar Ridge Augmentation Using Minimally Invasive Subperiosteal Tunneling With Xenogenic Bone Graft and PRF

Not Applicable
Not yet recruiting
Conditions
Alveolar Bone Loss
Registration Number
NCT07079917
Lead Sponsor
Fayoum University
Brief Summary

surgical horizontal augmentation for maxillary alveolar ridge using minimally invasive subperiosteal tunneling in comparison to conventional surgical technique

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Adults over 18 years old seeking an implant-supported restoration with deficient horizontal posterior maxillary alveolar ridge, at area of one or two missed teeth of less than 5 mm buccolingual width.
  • Minimum vertical height of 8 mm.
  • Gingival tissue of healthy adequate keratinization, more than 2mm.
Exclusion Criteria
  • The presence of uncontrolled diabetes or any other systemic condition which may complicate the surgical procedure or interfere with bone healing
  • Radiotherapy to the head and neck region
  • Chemotherapy within the last 12 months
  • Uncontrolled periodontitis
  • Smoking
  • Bisphosphonate therapy
  • Pregnancy
  • Presence of periapical infection or lesion

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Maxillary alveolar bone width6 months

increase of the alveolar bone buccolingually for horizontal ridge augmentation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fayoum University

🇪🇬

Fayoum, Egypt

Fayoum University
🇪🇬Fayoum, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.